The IPD and Alphabet’s DeepMind recently developed AI-powered tools to predict the three-dimensional structure of proteins, a long-standing problem in biomedicine. Science named the advance the “Breakthrough of the Year” for 2021 and its editor-in-chief called it “one of the greatest ever in terms of both the scientific achievement and the enabling of future research.” Both tools are already being leveraged by industry for the development of new therapeutics; IPD’s tool is called RoseTTAFold. First author on the key IPD study was UW computational chemist Minkyung Baek in the lab of IPD head David Baker.